1. Home
  2. LEGN

LEGN

Legend Biotech Corporation

Logo Legend Biotech Corporation

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

as 04-12-2024 10:30am EST

$
-
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's lead product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.

Founded: 2014 Country:
United States
United States
Employees: N/A City: N/A
Market Cap: 10.1B IPO Year: 2020
Target Price: $83.73 AVG Volume (30 days): 986.9K
Analyst Decision: Buy Number of Analysts: 13
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -2.94 EPS Growth: N/A
52 Week Low/High: $50.52 - $77.32 Next Earning Date: 05-13-2024
Revenue: $285,143,000 Revenue Growth: 143.70%
Revenue Growth (this year): 107.84% Revenue Growth (next year): 91.35%

Share on Social Networks: